Literature DB >> 24705578

Distribution of lymph node metastasis sites in endometrial cancer undergoing systematic pelvic and para-aortic lymphadenectomy: a proposal of optimal lymphadenectomy for future clinical trials.

Tetsuji Odagiri1, Hidemichi Watari, Tatsuya Kato, Takashi Mitamura, Masayoshi Hosaka, Satoko Sudo, Mahito Takeda, Noriko Kobayashi, Peixin Dong, Yukiharu Todo, Masataka Kudo, Noriaki Sakuragi.   

Abstract

PURPOSE: The aim of this study was to demonstrate the precise mapping of lymph node metastasis (LNM) sites in endometrial cancer.
METHODS: A total of 266 patients who underwent primary radical surgery including systematic pelvic and para-aortic lymphadenectomy for endometrial cancer from 1993 to 2010 were enrolled in this study. We removed lymph nodes from the femoral ring to the para-aortic node up to the level of renal veins. We analyzed the distribution of positive-node sites according to their anatomical location.
RESULTS: Overall, 42 of 266 patients (15.8 %) showed LNM. The median number of nodes harvested was 62.5 (range 40-119) in pelvic nodes (PLN), and 20 (range 3-47) in para-aortic nodes (PAN). Among 42 cases with positive-nodes, 16 cases (38.1 %) showed positive PLN alone, 7 cases (16.7 %) in PAN alone, and 19 cases (45.2 %) in both PLN and PAN. The most prevalent site of positive-nodes was PAN (9.8 %) followed by obturator nodes (9.4 %), internal iliac nodes (7.1 %), and common iliac nodes (5.6 %). Six of 19 cases (31.6 %) of positive PAN above the inferior mesenteric artery (IMA) showed negative PAN below IMA. Metastasis to the deep inguinal nodes was found to be extremely rare (0.38 %). Single-site LNM was the most frequently observed in obturator nodes, followed by PAN above IMA.
CONCLUSION: Routine resection of deep inguinal nodes is not recommended, whereas para-aortic lymphadenectomy should be extended up to the level of renal veins for endometrial cancer.

Entities:  

Mesh:

Year:  2014        PMID: 24705578     DOI: 10.1245/s10434-014-3663-0

Source DB:  PubMed          Journal:  Ann Surg Oncol        ISSN: 1068-9265            Impact factor:   5.344


  6 in total

1.  Lymphadenectomy should be performed up to the renal vein in patients with intermediate-high risk endometrial cancer.

Authors:  Ismail Alay; Taner Turan; Isin Ureyen; Alper Karalok; Tolga Tasci; Ahmet Ozfuttu; M Faruk Kose; Gokhan Tulunay
Journal:  Pathol Oncol Res       Date:  2015-01-07       Impact factor: 3.201

2.  Implications of para-aortic lymph node metastasis in patients with endometrial cancer without pelvic lymph node metastasis.

Authors:  Yukiharu Todo; Sho Takeshita; Kazuhira Okamoto; Katsushige Yamashiro; Hidenori Kato
Journal:  J Gynecol Oncol       Date:  2017-05-22       Impact factor: 4.401

3.  Inguinal lymph node presenting as the delayed site of metastasis in early stage endometrial carcinoma: Case report.

Authors:  Shomaila Amir M Akbar; Mutahir A Tunio; Wafa AlShakweer; AbdulAziz AlObaid; Mushabbab AlAsiri
Journal:  Int J Surg Case Rep       Date:  2017-01-19

4.  Effect of Lymphadenectomy on Survival in Early-Stage Type II Endometrial Carcinoma and Carcinosarcoma.

Authors:  Dogan Vatansever; Hamdullah Sozen; Gulcin Sahin Ersoy; Burak Giray; Samet Topuz; A Cem Iyibozkurt; Yavuz Salihoglu
Journal:  J Oncol       Date:  2020-04-10       Impact factor: 4.375

5.  A Lymph Node Count-Based AJCC Staging System Facilitates a More Accurate Prediction of the Prognosis of Patients With Endometrial Cancer.

Authors:  Xinlong Huo; Shufang Wang
Journal:  Front Oncol       Date:  2021-03-03       Impact factor: 6.244

6.  Less Invasive Endometrial Cancer Surgery with Extraperitoneal Pelvic and Para-aortic Lymphadenectomy via a Small Midline Abdominal Incision and the Retroperitoneal Approach.

Authors:  Shinichi Komiyama; Chiaki Takeya; Rena Takahashi; Sumito Nagasaki; Kaneyuki Kubushiro
Journal:  J Cancer       Date:  2016-04-29       Impact factor: 4.207

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.